Pantoprazole versus ranitidine in the treatment of duodenal ulcer: A multicenter study in Brazil

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 62-66

  Meneghelli, Ulysses G ^a   Zaterka, Schlioma ^a,b   De Paula Castro, Luiz ^c   Malafaia, Osvaldo ^d   Costa Lyra, Luiz Guilherme ^e,f  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Paediatric Rheumatology Division   (Brazil)

^e FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^f San Rafael Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUODENUM ULCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; TREATMENT OUTCOME; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; SULFOXIDES;

EID: 0033988771     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00804-7     Document Type: Article

References (35)

1. Fellenius E., Berglindh T., Sacks G., et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase. Nature. 290:1981;159-161.
2. Elander B., Fellenius E., Leth R., et al. Inhibitory action of omeprazole on acid acid formation in gastric glands and on the H+, K+-ATPase isolated from human gastric mucosa. Scand J Gastroenterol. 21:1986;268-272.
3. Zaterka S., Ferreira J.C.R., Neves D. Cimetidina no tratamento da ulcera duodenal. Estudo duplamente cego. Rev Hosp Clin Fac Med S Paulo. 33:1978;5-11.
4. McIsaac R.L., McCanless I., Summers K., et al. Ranitidine and cimetidine in the healing of duodenal ulcer Meta-analysis of comparative clinical trials . Aliment Pharmacol Therap. 1:1987;369-381.
5. Feldman M., Burton M.E. Histamine2-receptor antagonists Standard therapy for acid-peptic disease . N Engl J Med. 323:1990;1749-1755.
6. Burget D.W., Chiverton S.G., Hunt R.H. Is there an optimal degree of acid suppression for healing of duodenal ulcers? Gastroenterology. 99:1990;345-351.
7. Savary M., Miller G. The esophagus - Handbook and atlas of endoscopy. 1978;Solothurn Gasman.
8. Neter J., Wasserman W., Kuther M.H. Applied link statistical models. 1995;Irwin Press, Homewood, IL.
9. Gastric secretion and duodenal ulcer healing during treatment with omeprazole. Scand J Gastroenterol. 19:1984;882-884.
10. Omeprazole in duodenal ulceration, acid inhibition, symptom relief, endoscopic healing and recurrence. Br Med J. 289:1984;525-528.
11. Blanchi A., Rotenberg A., Soulé J.-C., et al. Traitement d'ulcére duodénal en pousée par l'oméprazole. Gastroenterol Clin Biol. 8:1984;943-946.
12. Londong W., Barth H., Dammann H.G., et al. Dose-related healing of duodenal ulcer with a proton pump inhibitor lanzoprazole. Alimen Pharmacol Ther. 5:1991;245-254.
13. Müller P., Simon B., Khalil K., et al. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Z Gastroenterol. 30:1992;771-775.
14. Koelz H.R., Judmaier G. Double-blind comparison of pantoprazole and ranitidine in short-term treatment of acute duodenal ulcer. Gastroenterology. 104:1993;A121.
15. Bardhan K.D., Cherian P., Polak J.M., et al. Pantoprazole (PANTO) in aggressive or refractory acid-peptic disease. Gastroenterology. 110:(suppl):1996;A57.
16. Brunner G., Harke U., Schneider A., et al. Long-term management of H2-blocker refractory acid-peptic disease with pantoprazole. Gastroenterology. 110:(suppl):1996;A70.
17. Zaterka S., Eisig J.N., Chinzon D. Gastrinoma - Diagnóstico e Tratamento. Gastroclinica. 1:1993;7-14.
18. Bader J.P., Delchier J.C. Clinical afficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther. 8:(suppl 1):1994;47-52.
19. Judmaier G., Koeltz H.R. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Aliment Pharmacol Ther. 8:1994;81-86.
20. van Rensburg C.J., van Eeden P.J., Marks I.N., et al. Improved duodenal ulcer healing with pantoprazole compared with ranitidine A multicenter study . Gastroenterology. 104:1993;A217. (abstract).
21. Schepp W., Classen M. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Scand J Gastroenterol. 30:1995;511-514.
22. Dibildox M., Rose K., Tomas Pons J., et al. Superiority of pantoprazole over ranitidine in the treatment of duodenal ulcer. Ver Gastroenterol Mex. 61:1996;193-198.
23. Bardhan K.D., Bianchi Porro G., Bose K., et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol. 8:1986;408-413.
24. Marks I.N., Winter T.A., Lucke W., et al. Omeprazole and ranitidine in duodenal ulcer healing. S Afr Med J. 74:(suppl):1988;54-56.
25. Zaterka S., Massuda H., Chinzon D., et al. Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population A multicenter double-blind, parallel group study . Am J Gastroenterol. 88:1993;397-401.
26. Miszputen S.J., Vilela M.P., Kondo M., et al. Estudo multicentrico comparativo entre omeprazol e ranitidina na úlcera duodenal. GED. 16:1997;127-134.
27. Hawkey C.J., Long R.G., Bardhan K.D., et al. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut. 34:1993;1458-1462.
28. Lanza F., Goff J., Scowcroft C., et al. Double-blind comparison of lansoprazole, ranitidine and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. Am J Gastroenterol. 89:1994;1191-1200.
29. Russo A., Dattilo M. Bedtime administration of lansoprazole does not modify its greater efficacy in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double-blind clinical trial. Ital J Gastroenterol Hepatol. 29:1997;312-319.
30. Hartmann M., Theiss U., Huber R., et al. Twenty-four hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison with omeprazole. Aliment Pharmacol Ther. 10:1996;359-366.
31. Dammann H.G., Burkhardt F. Influence of pantoprazole 40 mg and omeprazole 20 mg on meal-stimulated gastric acid secretion. Gut. 41:(suppl 3):1997;A98.
32. Simon W.A., Buedingen C., Fahr S., et al. The H+, K+-ATPase inhibitor pantoprazole (BYK1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lanzoprazole. Biochem Pharmacol. 42:1991;347-355.
33. Meyer U.A. Interaction of proton pump inhibitors with cytochromes P450 Consequences for drug interactions . Y J Biol Med. 69:1996;203-209.
34. Steinijans V.W., Huber M., Hartmann M., et al. Lack of pantoprazole drug interactions in man. Int J Clin Pharmacol Ther. 32:1994;385-399.
35. Benet L.Z., Zech K. Pharmacokinectics - A relevant factor for the choice of a drug. Aliment Pharmacol Ther. 8:(suppl 1):1994;25-32.